Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.1994 · 283 citations
2. 2Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia2001 · 50 citations
3. 3Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate–resistant Bcr-Abl kinases2002 · 136 citations
4. 4Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment2002 · 520 citations